Moreover, it has been detected in various cancer cell lines, including those of sarcoma, multiple myeloma, chronic myeloid leukemia, lung cancer, and breast cancer (such as the BT20 breast cancer cell line, which lacks both estrogen and progesterone receptors). Here, PGR is linked to breast cancer.